ValiRx plc (EAJF) Financial Statements
ValiRx plc Financial Overview
ValiRx plc's market cap is currently $2.68M. The company's EPS TTM is $-0.00; its P/E ratio is -0.89; ValiRx plc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 31.37K | $ 49.77K | $ 9.60K | $ 0.00 | $ 0.00 |
| Gross Profit | $ -6.25K | $ -217.22K | $ -246.04K | $ -224.27K | $ -228.79K |
| Operating Income | $ -1.82M | $ -2.14M | $ -2.30M | $ -2.59M | $ -1.68M |
| EBITDA | $ -2.18M | $ -1.86M | $ -2.04M | $ -2.38M | $ -1.45M |
| Net Income | $ -2.23M | $ -1.92M | $ -2.04M | $ -2.41M | $ -1.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 791.61K | $ 1.56M | $ 174.68K | $ 1.14M | $ 593.67K |
| Total Assets | $ 2.63M | $ 4.26M | $ 3.13M | $ 3.98M | $ 3.52M |
| Total Debt | $ 1.40K | $ 11.86K | $ 22.07K | $ 37.71K | $ 58.72K |
| Net Debt | $ -790.22K | $ -1.54M | $ -152.61K | $ -1.10M | $ -534.95K |
| Total Liabilities | $ 235.10K | $ 346.41K | $ 226.51K | $ 149.65K | $ 109.56K |
| Stockholders' Equity | $ 2.86M | $ 4.32M | $ 3.22M | $ 4.05M | $ 3.60M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.52M | $ -1.62M | $ -2.08M | $ -1.71M | $ -1.26M |
| Operating Cash Flow | $ -1.51M | $ -1.58M | $ -1.77M | $ -1.71M | $ -1.26M |
| Investing Cash Flow | $ -13.58K | $ -38.16K | $ -306.18K | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 759.35K | $ 3.00M | $ 1.12M | $ 2.26M | $ 7.34K |
Currency in GBP